Pharmacology Elagolix sodium was approved by FDA in July 2018 for A Prostate cancer B Pain of endometriosis C Dysmenorrhea D Non-Hodgkins lymphoma 💡 Explanation Elagolix sodium was approved by FDA in July 2018 for ✓ Correct Answer: B. Pain of endometriosis